Generation of an immune microenvironment as a novel mechanism for myotoxins to potentiate genetic vaccines

Vaccine

Volumn 28, Issue 50, 2010, Pages 7970-7978

  Qin, Hong ^a   Cha, Soung chul ^a   Neelapu, Sattva S ^a   Liu, Chengwen ^a   Wang, Yi Hong ^a   Wei, Jinsong ^a   Qin, Xiao Feng ^a   Liu, Yong Jun ^a   Kwak, Larry W ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Adaptive T cell immunity; Immune adjuvant; Immune microenvironment; Myotoxin

Indexed keywords

CARDIOTOXIN; CD40 ANTIGEN; CYTOKINE; DNA VACCINE; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; DNA FINGERPRINTING; GENE EXPRESSION PROFILING; IMMUNE MICROENVIRONMENT; IMMUNOSTIMULATION; INFLAMMATION; MICROENVIRONMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION;

ADAPTIVE IMMUNITY; ADJUVANTS, IMMUNOLOGIC; ANIMALS; CARDIOTOXINS; CYTOKINES; DENDRITIC CELLS; IMMUNITY, INNATE; INFLAMMATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; T-LYMPHOCYTES; TOLL-LIKE RECEPTORS; UP-REGULATION; VACCINATION; VACCINES, DNA;

EID: 78650255642     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.09.084     Document Type: Article

References (47)

1. Dubensky T.W., Campbell B.A., Villarreal L.P. Direct transfection of viral and plasmid DNA into the liver or spleen of mice. Proc Natl Acad Sci USA 1984, 81(23):7529-7533.
2. Benvenisty N., Reshef L. Direct introduction of genes into rats and expression of the genes. Proc Natl Acad Sci USA 1986, 83(24):9551-9555.
3. Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A., et al. Direct gene transfer into mouse muscle in vivo. Science 1990, 247(4949 Pt 1):1465-1468.
4. Tang D.C., DeVit M., Johnston S.A. Genetic immunization is a simple method for eliciting an immune response. Nature 1992, 356(6365):152-154.
5. Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes G.H., Felgner P.L., Dwarki V.J., et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993, 259(5102):1745-1749.
6. Kwak L.W., Campbell M.J., Czerwinski D.K., Hart S., Miller R.A., Levy R. Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. N Engl J Med 1992, 327(17):1209-1215.
7. Bendandi M., Gocke C.D., Kobrin C.B., Benko F.A., Sternas L.A., Pennington R., et al. Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma. Nat Med 1999, 5(10):1171-1177.
8. Rosenberg S.A., Yang J.C., Schwartzentruber D.J., Hwu P., Topalian S.L., Sherry R.M., et al. Recombinant fowlpox viruses encoding the anchor-modified gp100 melanoma antigen can generate antitumor immune responses in patients with metastatic melanoma. Clin Cancer Res 2003, 9(8):2973-2980.
9. Schuster S., Neelapu S., Gause B., Muggia J., Gockerman E., Sotomayor J., et al. Idiotype vaccine therapy (BiovaxIDTM) in follicular lymphoma in first complete remission: phase III clinical trial results. ASCO Annual Meeting (abstr) 2009.
10. Sumida S.M., McKay P.F., Truitt D.M., Kishko M.G., Arthur J.C., Seaman M.S., et al. Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines. J Clin Invest 2004, 114(9):1334-1342.
11. Weiner G.J., Liu H.M., Wooldridge J.E., Dahle C.E., Krieg A.M. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. Proc Natl Acad Sci USA 1997, 94(20):10833-10837.
12. Lore K., Betts M.R., Brenchley J.M., Kuruppu J., Khojasteh S., Perfetto S., et al. Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses. J Immunol 2003, 171(8):4320-4328.
13. Diehl L., den Boer A.T., Schoenberger S.P., van der Voort E.I., Schumacher T.N., Melief C.J., et al. CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy. Nat Med 1999, 5(7):774-779.
14. Sikora A.G., Jaffarzad N., Hailemichael Y., Gelbard A., Stonier S.W., Schluns K.S., et al. IFN-alpha enhances peptide vaccine-induced CD8+ T cell numbers, effector function, and antitumor activity. J Immunol 2009, 182(12):7398-7407.
15. Cavassani K.A., Ishii M., Wen H., Schaller M.A., Lincoln P.M., Lukacs N.W., et al. TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J Exp Med 2008, 205(11):2609-2621.
16. Wu C.J., Lee S.C., Huang H.W., Tao M.H. In vivo electroporation of skeletal muscles increases the efficacy of Japanese encephalitis virus DNA vaccine. Vaccine 2004, 22(11-12):1457-1464.
17. Qin H., Cha S.C., Neelapu S.S., Lou Y., Wei J., Liu Y.J., et al. Vaccine site inflammation potentiates idiotype DNA vaccine-induced therapeutic T cell-, and not B cell-, dependent antilymphoma immunity. Blood 2009, 114(19):4142-4149.
18. Biragyn A., Tani K., Grimm M.C., Weeks S., Kwak L.W. Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity. Nat Biotechnol 1999, 17(3):253-258.
19. Biragyn A., Surenhu M., Yang D., Ruffini P.A., Haines B.A., Klyushnenkova E., et al. Mediators of innate immunity that target immature, but not mature, dendritic cells induce antitumor immunity when genetically fused with nonimmunogenic tumor antigens. J Immunol 2001, 167(11):6644-6653.
20. Biragyn A., Ruffini P.A., Leifer C.A., Klyushnenkova E., Shakhov A., Chertov O., et al. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 2002, 298(5595):1025-1029.
21. Scumpia P.O., McAuliffe P.F., O'Malley K.A., Ungaro R., Uchida T., Matsumoto T., et al. CD11c+ dendritic cells are required for survival in murine polymicrobial sepsis. J Immunol 2005, 175(5):3282-3286.
22. Schiavoni G., Mattei F., Sestili P., Borghi P., Venditti M., Morse H.C., et al. ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8alpha(+) dendritic cells. J Exp Med 2002, 196(11):1415-1425.
23. Tsujimura H., Tamura T., Ozato K. Cutting edge: IFN consensus sequence binding protein/IFN regulatory factor 8 drives the development of type I IFN-producing plasmacytoid dendritic cells. J Immunol 2003, 170(3):1131-1135.
24. Takaoka A., Yanai H., Kondo S., Duncan G., Negishi H., Mizutani T., et al. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 2005, 434(7030):243-249.
25. Stetson D.B., Medzhitov R. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 2006, 24(1):93-103.
26. Tailor P., Tamura T., Kong H.J., Kubota T., Kubota M., Borghi P., et al. The feedback phase of type I interferon induction in dendritic cells requires interferon regulatory factor 8. Immunity 2007, 27(2):228-239.
27. Wiethe C., Dittmar K., Doan T., Lindenmaier W., Tindle R. Provision of 4-1BB ligand enhances effector and memory CTL responses generated by immunization with dendritic cells expressing a human tumor-associated antigen. J Immunol 2003, 170(6):2912-2922.
28. Adachi O., Kawai T., Takeda K., Matsumoto M., Tsutsui H., Sakagami M., et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 1998, 9(1):143-150.
29. Wu C.J., Li T.L., Huang H.W., Tao M.H., Chan Y.L. Development of an effective Japanese encephalitis virus-specific DNA vaccine. Microbes Infect 2006, 8(11):2578-2586.
30. Arulkanthan A., Brown W.C., McGuire T.C., Knowles D.P. Biased immunoglobulin G1 isotype responses induced in cattle with DNA expressing msp1a of Anaplasma marginale. Infect Immun 1999, 67(7):3481-3487.
31. Fomsgaard A., Nielsen H.V., Nielsen C., Johansson K., Machuca R., Bruun L., et al. Comparisons of DNA-mediated immunization procedures directed against surface glycoproteins of human immunodeficiency virus type-1 and hepatitis B virus. APMIS 1998, 106(6):636-646.
32. Teixeira C.F., Zamuner S.R., Zuliani J.P., Fernandes C.M., Cruz-Hofling M.A., Fernandes I., et al. Neutrophils do not contribute to local tissue damage, but play a key role in skeletal muscle regeneration, in mice injected with Bothrops asper snake venom. Muscle Nerve 2003, 28(4):449-459.
33. Rosato A., Zoso A., Milan G., Macino B., Dalla Santa S., Tosello V., et al. Individual analysis of mice vaccinated against a weakly immunogenic self tumor-specific antigen reveals a correlation between CD8 T cell response and antitumor efficacy. J Immunol 2003, 171(10):5172-5179.
34. Wille-Reece U., Wu C.Y., Flynn B.J., Kedl R.M., Seder R.A. Immunization with HIV-1 Gag protein conjugated to a TLR7/8 agonist results in the generation of HIV-1 Gag-specific Th1 and CD8+ T cell responses. J Immunol 2005, 174(12):7676-7683.
35. Chattergoon M.A., Robinson T.M., Boyer J.D., Weiner D.B. Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophages/antigen-presenting cells. J Immunol 1998, 160(12):5707-5718.
36. Urbonaviciute V., Furnrohr B.G., Meister S., Munoz L., Heyder P., De Marchis F., et al. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J Exp Med 2008, 205(13):3007-3018.
37. Liu B., Dai J., Zheng H., Stoilova D., Sun S., Li Z. Cell surface expression of an endoplasmic reticulum resident heat shock protein gp96 triggers MyD88-dependent systemic autoimmune diseases. Proc Natl Acad Sci USA 2003, 100(26):15824-15829.
38. Fujii S., Liu K., Smith C., Bonito A.J., Steinman R.M. The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J Exp Med 2004, 199(12):1607-1618.
39. Cho H.J., Hayashi T., Datta S.K., Takabayashi K., Van Uden J.H., Horner A., et al. IFN-alpha beta promote priming of antigen-specific CD8+ and CD4+ T lymphocytes by immunostimulatory DNA-based vaccines. J Immunol 2002, 168(10):4907-4913.
40. Kolumam G.A., Thomas S., Thompson L.J., Sprent J., Murali-Krishna K. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med 2005, 202(5):637-650.
41. Curtsinger J.M., Valenzuela J.O., Agarwal P., Lins D., Mescher M.F. Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J Immunol 2005, 174(8):4465-4469.
42. Thompson L.J., Kolumam G.A., Thomas S., Murali-Krishna K. Innate inflammatory signals induced by various pathogens differentially dictate the IFN-I dependence of CD8 T cells for clonal expansion and memory formation. J Immunol 2006, 177(3):1746-1754.
43. Timmerman J.M., Singh G., Hermanson G., Hobart P., Czerwinski D.K., Taidi B., et al. Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma. Cancer Res 2002, 62(20):5845-5852.
44. Qin H., Nehete P.N., He H., Nehete B., Buchl S., Cha S.C., et al. Prime-boost vaccination using chemokine-fused gp120 DNA and HIV envelope peptides activates both immediate and long-term memory cellular responses in rhesus macaques. J Biomed Biotechnol 2010, 860160.
45. Costa L.A., Miles H.A., Diez R.A., Araujo C.E., Coni Molina C.M., Cervellino J.C. Phase I study of VRCTC-310, a purified phospholipase A2 purified from snake venom, in patients with refractory cancer: safety and pharmacokinetic data. Anticancer Drugs 1997, 8(9):829-834.
46. Cura J.E., Blanzaco D.P., Brisson C., Cura M.A., Cabrol R., Larrateguy L., et al. Phase I and pharmacokinetics study of crotoxin (cytotoxic PLA(2), NSC-624244) in patients with advanced cancer. Clin Cancer Res 2002, 8(4):1033-1041.
47. Liu C., Lou Y., Lizee G., Qin H., Liu S., Rabinovich B., et al. Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice. J Clin Invest 2008, 118(3):1165-1175.